Xanthus Pharma Raises $25 Million

Xanthus Pharmaceuticals Inc., a Cambridge, Mass.-based oncology drug development company, has raised $25 million in additional Series B funding. Return backers include HealthCare Ventures, GeneChem, GIMV, Hambrecht & Quist Capital Management, Still River Fund, Neomed, Kestrel Ventures, CDP Capital, CDIB BioScience Ventures and Yasuda. Xanthus has now raised $88 million in total VC funding. www.xanthus.com